Nirianne Palacpac

RH5.1/Matrix-M: highlighting blood-stage malaria vaccines

Nirianne Palacpac, Toshihiro Horii

jp (code pays fourni par la source)

Understanding the immunogenicity of RTS,S in infants

Nirianne Palacpac, Toshihiro Horii

jp (code pays fourni par la source)

Peer Review Report For: Social, Ethical and Regulatory implications of conducting a malaria Vaccine Efficacy trial in a human infection study in Kenya (SERVE-Kenya): A study protocol [version 1; peer review: 1 approved, 1 approved with reservations, 1 not approved]

Nirianne Palacpac

Asymptomatic parasitemia and RTS,S vaccine efficacy

Nobuko Arisue, Nirianne Palacpac

jp (code pays fourni par la source)

Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria

Issa Nébié, Nirianne Palacpac, Edith C. Bougouma, Amidou Diarra et autres

Burkina Faso, jp, de, gb (code pays fourni par la source)

Immune tolerance caused by repeated P. falciparum infection against SE36 malaria vaccine candidate antigen and the resulting limited polymorphism

Nirianne Palacpac, Ken J. Ishii, Nobuko Arisue, Takahiro Tougan et autres

jp (code pays fourni par la source)

PA-435 Long-term immune response in children vaccinated with BK-SE36/CpG blood stage malaria candidate vaccine in a malaria hyperendemic and seasonal area of Burkina Faso

Nirianne Palacpac, Edith C. Bougouma, Amidou Diarra, Alfred B. Tiono et autres

Burkina Faso, jp, de (code pays fourni par la source)

PA-463 Phase 1b randomized, controlled, double-blinded, age de-escalation trial to evaluate the safety, reactogenicity and immunogenicity of BK-SE36/CpG malaria vaccine in Burkinabe healthy adults and children

Alphonse Ouédraogo, Edith C. Bougouma, Sophie Houard, Nirianne Palacpac et autres

de, jp, Burkina Faso (code pays fourni par la source)

Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial

Alphonse Ouédraogo, Edith C. Bougouma, Nirianne Palacpac, Sophie Houard et autres

Burkina Faso, jp, de, gb (code pays fourni par la source)

Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children

Alfred B. Tiono, Nirianne Palacpac, Edith C. Bougouma, Issa Nébié et autres

Burkina Faso, jp, de (code pays fourni par la source)

Editorial: Puzzle pieces from malaria vaccine clinical trials

Nirianne Palacpac, Alfred B. Tiono, Benjamin Mordmüller, Takafumi Tsuboi

jp, Burkina Faso, nl (code pays fourni par la source)

African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination

Nobuko Arisue, Nirianne Palacpac, Edward Hosea Ntege, Adoke Yeka et autres

jp, Ouganda, Kenya, Burkina Faso, de (code pays fourni par la source)